SCHEMBL284174

SCHEMBL284174

C=COC(=O)OCCCCCCOC(=O)OC=C

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.54
ALDH1A1 P00352 3/20 0.54
CYP3A4 P08684 1/20 0.54
HPGD P15428 1/20 0.39
NAAA Q02083 1/20 0.35
HCAR2 Q8TDS4 1/20 0.34
HTT P42858 1/20 0.34
TP53 P04637 2/20 0.33
HIF1A Q16665 2/20 0.33
EPHX1 P07099 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ACHE P22303 6/20 0.32
LPAR2 Q9HBW0 1/20 0.32
LPAR3 Q9UBY5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL284885 0.98 TSHR (0.50) TSHRALDH1A1CYP3A4HPGDNAAA
SCHEMBL1799910 0.93 TSHR (0.44) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL5792196 0.92 TSHR (0.47) TSHRALDH1A1CYP3A4HPGDNAAA
SCHEMBL13415316 0.90 TSHR (0.45) TSHRALDH1A1CYP3A4HPGDNAAA
SCHEMBL13786723 0.90 NAAA (0.52) TSHRALDH1A1CYP3A4HPGDNAAA
SCHEMBL3666982 0.90 NAAA (0.52) TSHRALDH1A1CYP3A4HPGDNAAA
SCHEMBL10519867 0.90 NAAA (0.52) TSHRALDH1A1CYP3A4HPGDNAAA
SCHEMBL28593490 0.90 NAAA (0.52) TSHRALDH1A1CYP3A4HPGDNAAA
SCHEMBL18864334 0.90 NAAA (0.52) TSHRALDH1A1CYP3A4HPGDNAAA
SCHEMBL30034385 0.90 NAAA (0.52) TSHRALDH1A1CYP3A4HPGDNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3091050-B1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE SYNTHES GMBH (CH) 2018-07-18 EP claimed
US-9814801-B2 Thiol-ene polymerization with vinylesters and vinylcarbonate DePuy Synthes Products, Inc. (US) 2017-11-14 US claimed
EP-3091050-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE Synthes GmbH (CH) 2016-11-09 EP claimed
US-20160243279-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE SYNTHES GMBH (CH) 2016-08-25 US claimed
EP-2764049-B1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE SYNTHES GMBH (CH) 2016-08-17 EP claimed
US-20130084543-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE TECHNISCHE UNIVERSITAT WIEN (AT) 2013-04-04 US claimed
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO claimed
WO-2003057896-A1 METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO claimed
US-6261813-B1 ACYLATING PACLITAXEL WITH BIFUNCTIONAL ACYL DONOR USING HYDROLASE TO FORM ACTIVATED ACYL ESTER OR CARBONATE, THEN ACYLATING NUCLEOPHILE WITH ACTIVATED ESTER OR CARBONATE IN PRESENCE OF HYDROLASE; IMPROVED WATER SOLUBILITY ALBANY MOLECULAR RESEARCH, INC. 2001-07-17 US claimed
EP-3091050-B1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE SYNTHES GMBH (CH) 2018-07-18 EP disclosed
US-9814801-B2 Thiol-ene polymerization with vinylesters and vinylcarbonate DePuy Synthes Products, Inc. (US) 2017-11-14 US disclosed
US-9814801-B2 Thiol-ene polymerization with vinylesters and vinylcarbonate DePuy Synthes Products, Inc. (US) 2017-11-14 US disclosed
US-9814801-B2 Thiol-ene polymerization with vinylesters and vinylcarbonate DePuy Synthes Products, Inc. (US) 2017-11-14 US disclosed
US-9623145-B2 Thiol-ene polymerization with vinylesters and vinylcarbonate DePuy Synthes Products, Inc. (US) 2017-04-18 US disclosed
WO-2009065162-A2 COMPOSITION THAT CAN BE CURED BY POLYMERISATION FOR THE PRODUCTION OF BIODEGRADABLE, BIOCOMPATIBLE, CROSS-LINKABLE POLYMERS ON THE BASIS OF POLYVINYL ALCOHOL TECHNISCHE UNIVERSITÄT WIEN (AT) 2009-05-28 WO disclosed
US-20090047717-A1 ENZYME-CATALYZED POLYCARBONATE AND POLYCARBONATE ESTER SYNTHESIS SyntheZyme, LLC 2009-02-19 US disclosed
WO-2006012277-A2 BIOCATALYTIC PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED PRAMIPEXOLE AMR TECHNOLOGY, INC. (US) 2006-02-02 WO disclosed
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO disclosed
WO-2003057896-A1 METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO disclosed
US-6261813-B1 ACYLATING PACLITAXEL WITH BIFUNCTIONAL ACYL DONOR USING HYDROLASE TO FORM ACTIVATED ACYL ESTER OR CARBONATE, THEN ACYLATING NUCLEOPHILE WITH ACTIVATED ESTER OR CARBONATE IN PRESENCE OF HYDROLASE; IMPROVED WATER SOLUBILITY ALBANY MOLECULAR RESEARCH, INC. 2001-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130084543-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE TMT1A, MGMT, CBS TSHR 2137/4885ALDH1A1 335/4885CYP3A4 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.